The Clorox Company (NYSE:CLX) Stock Holdings Reduced by Harvey Investment Co. LLC

Harvey Investment Co. LLC cut its position in shares of The Clorox Company (NYSE:CLX) by 9.0% in the third quarter, Holdings Channel reports. The firm owned 9,150 shares of the company’s stock after selling 900 shares during the period. Harvey Investment Co. LLC’s holdings in Clorox were worth $1,491,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CLX. GoalVest Advisory LLC acquired a new position in Clorox in the first quarter worth approximately $31,000. First Foundation Advisors acquired a new position in shares of Clorox during the 1st quarter worth $31,000. Innealta Capital LLC bought a new position in shares of Clorox during the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC lifted its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Finally, Quarry LP boosted its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE:CLX opened at $158.73 on Thursday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a 50-day moving average price of $160.25 and a 200 day moving average price of $145.43. The firm has a market capitalization of $19.71 billion, a PE ratio of 82.40, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Research analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.51% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CLX. TD Cowen started coverage on Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. JPMorgan Chase & Co. boosted their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Citigroup boosted their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Finally, Barclays raised their target price on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research note on Friday, October 11th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $150.14.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.